The early use of Antibiotics in at Risk CHildren with InfluEnza Eligibility assessment and recruitment tips www.archiestudy.com.

Slides:



Advertisements
Similar presentations
Respiratory tract infections - antibiotic prescribing
Advertisements

Chest Infections Lawrence Pike.
Atrial Fibrillation Service
Dr. David Pearson Gastroenterology, Victoria.  None relevant to this presentation.
Influenza and Influenza Vaccine
Sickle Cell Disease: Core Concepts for the Emergency Physician and Nurse Acute Chest Syndrome Spring 2013.
Influenza (The Flu).
BVCOG HRSA/HAB Tier 2 and 3 Performance Measures Lisa Cornelius, MD, MPH July 2010.
Pneumonia: nursing management Islamic University Nursing College.
Dr. Simon Benson GP Specialist Trainee. Introduction Diagnosis of pneumonia in children with wheeze is difficult Limited data exists regarding predictors.
INFLUENZA COMPLICATIONS. Influenza complications Bacterial superinfections – bacterial pneumonia – croup – respiratory disorders Decompensation of chronic.
AAP Clinical Practice Guideline: Management of Sinusitis Pediatrics 108:798, 2001 (Sep)
Influenza Vaccination
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
Public Health Update David Kirschke, MD Medical Director / Health Officer Northeast Tennessee Regional Health Office.
ESRD Network 6 5 Diamond Patient Safety Program
Antibiotic Use in URTI Gary Kroukamp ENT Specialist Kingsbury Hospital.
RESPIRATORY TRACT INFECTIONS: ANTIBIOTIC PRESCRIBING
MEASLES Katie Townes, MD UMass Medical School and HEARTT Emmanuel Okoh, MD Acting Director of Pediatrics, JFKMC and HEARTT Adapted from a lecture by Rick.
Internal Medicine Propedeutics. Goals Dentists don’t treat only healthy people Dental treatments can affect the patient health Dentists can discover some.
Developed By: Barbara (Bobbi) P. Clarke, PhD. RD Professor & Extension Health Specialist, Co-Director for The University of Tennessee Center for Community.
Pneumonia By: Larissa and Kyla.
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
H1N1 General Information Update Karen Dahl, MD Pediatric Infectious Diseases.
From Pandemic Preparedness to Management: UK experience Professor Lindsey Davies CBE FRCP FFPH National Director of Pandemic Influenza Preparedness.
Respiratory Syncytial Virus Prophylaxis The criteria
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
Infants and Young Children and Pandemic H1N1 Influenza Key learning from seasonal flu and previous pandemics Children less than 5 years of age have increased.
Communicable Disease Aim: How can someone contract a communicable disease?
PEDIATRIC ASTHMA Anna M. Suray, M.D Respiratory Update Weirton Medical Center March 17, 2008.
Bacterial Pneumonia.
RSV RT 265. Respiratory Syncytial Virus Manifests primarily as: Bronchiolitis Bronchiolitis Viral pneumonia Viral pneumonia Leading cause of lower respiratory.
MANAGEMENT FOR PAEDIATRIC PATIENT UNDER INVESTIGATION (PUI) WITH INFLUENZA-LIKE ILLNESS (ILI) IN OUTPATIENT SETTING CM CHOO HSAH 2013.
Pediatric Diagnosis Observation –Eye contact –Establish rapport with the parents & the child History taking –Investigation –Asking “relevant” questions.
APPLICATION OF AEROSOL BRONCHODILATOR IN CHILDRENWITH A SIBILANT (ASTMOID) BREATHING IN THE AGE OF 5 YEARS Kazakh National Medical University after name.
Differential Diagnosis of Asthma Dr. R. Amin Professor of Allergy and Clinical Immunology Shiraz University of Medical Sciences.
History taking and physical examination. KEY ELEMENTS Introduce yourself,(name and position) Rapport with patient, Beginning start with open ended questions,
MAJOR EVENTS AND EVOLUTION IN CYSTIC FIBROSIS PATIENTS Author: Alexandra Martin Coordinator: Dr. Reka Borka Balas University of Medicine and Pharmacy Târgu-
1 Vaccines Contraindications. Contraindications to any routine active immunization procedure An acute febrile illness, malaise, cough, diarrhea, or other.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
Bronchiolitis Abdullah M. Al-Olayan MBBS, SBP, ABP. Assistant Professor of Pediatrics. Pediatric Pulmonologist.
How It Is Spread  Burkholderia cepacia is spread by a person, typically not with the best health, doing an activity involving water and soil containing.
1 Influenza Vaccination 2016 Cluster: Communicable Disease, NDoH.
The early use of Antibiotics in at Risk CHildren with InfluEnza Medical notes review
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
Pneumonia Infection and inflammation of the lungs Alveoli fill with fluids and mucus resulting in coughing and difficulty breathing Treatment: medication.
The national flu immunisation programme Training for Receptionists 2015/2016.
Karyn Probert NHS Gloucestershire CCG
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
CIP ABSTRACT PRESENTATION
Infant born with mother Tuberculosis
The early use of Antibiotics in at Risk CHildren with InfluEnza www
Aishah Awatif Haziq Pre-operative evaluation and preparation (prior to procedure under general anesthesia)
VIROLOGY “RESPIRATORY VIRUSES IN CYSTIC FIBROSIS”
Chief Investigator: Dr Kay Wang Senior Trial Manager: Tricia Carver
The early use of Antibiotics in at Risk CHildren with InfluEnza
Chief Investigator: Dr Kay Wang Senior Trial Manager: Tricia Carver
DATABASE SEARCH & REVIEW GETTING STARTED GUIDE FOR EMIS WEB USERS
The early use of Antibiotics in at Risk CHildren with InfluEnza
Common Infectious Disease
The early use of Antibiotics in at Risk CHildren with InfluEnza
Swine Flu (H1N1) Biol 222 By: Khawla Zawahra.
The early use of Antibiotics in at Risk CHildren with InfluEnza www
The early use of Antibiotics in at Risk CHildren with InfluEnza
Flu vaccine What is flu? Benefits of the flu vaccine
بنام خداوند جان و خرد بنام خداوند جان و خرد.
March Quick Hits.
VIROLOGY “RESPIRATORY VIRUSES IN CYSTIC FIBROSIS”
Calculate Well’s score for PE (BOX1)
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Presentation transcript:

The early use of Antibiotics in at Risk CHildren with InfluEnza Eligibility assessment and recruitment tips

Dr Kay Wang ARCHIE Study Chief Investigator

Patients to consider for ARCHIE ‘At risk’ children aged 6 months to 12 years Cough AND fever* during influenza season (October to March) Within 5 days of symptom onset No known contraindication to co-amoxiclav Does not require immediate antibiotics or hospitalisation *Reported as symptom or temperature 37.9°C or higher during consultation

Full eligibility criteria

Inclusion criteria Add screenshot of online version.

Inclusion criteria Add screenshot of online version.

Key ‘at risk’ categories (see INCLUSION CRITERIA link) Prematurity in children aged 6 to 23 months – born at less than 37 weeks’ gestation Immunodeficiency – drugs, haematological conditions, malignancy, sickle cell disease Diabetes mellitus Neurological conditions – compromising respiratory function/handling of respiratory secretions Lung conditions – asthma requiring controller therapy, recurrent viral wheeze, hospitalisation within last 12 months (asthma, bronchiolitis). NOT cystic fibrosis. Cardiac conditions – being actively managed or monitored by specialist hospital team

Exclusion criteria Add screenshot of online version.

Known hypersensitivity to beta-lactam antibiotics or clavulanic acid History of jaundice or hepatic impairment due to co- amoxiclav Severe liver disease with jaundice, increased bleeding risk, bilirubin >50 micromol/litre (2 measurements within last 12 months) Known or suspected infectious mononucleosis Known phenylketonuria Any medication interactions eGFR less than 30 ml/min/1.73m 2 Contraindications to co-amoxiclav See EXCLUSION CRITERIA link

Recruitment timeframe Same day if possible Following (working) day if still eligibility criteria – Complete eligibility assessment form on the same day as the baseline assessment.

Face to face consultation Full eligibility assessment Baseline assessment Consider booking longer appointment or appointment at end of surgery Telephone consultation Initial eligibility assessment Introduce study (information leaflets on Study website Screen prompts (EMIS Web)

Screen prompt (EMIS Web) Consulting with any of the following: – Cough – Pyrexia – Influenza – Influenza-like illness – Upper respiratory tract infection – Viral illness Provided: – Age 6 months to 12 years – Coded ‘At risk of influenza-related complications’ (EMISNQAT42)

Record interest ‘in principle’

Thank you for listening